0001104659-19-033169.txt : 20190531
0001104659-19-033169.hdr.sgml : 20190531
20190531171249
ACCESSION NUMBER: 0001104659-19-033169
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190528
FILED AS OF DATE: 20190531
DATE AS OF CHANGE: 20190531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cambridge Innovation Capital (Jersey) Ltd
CENTRAL INDEX KEY: 0001776911
STATE OF INCORPORATION: Y9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38916
FILM NUMBER: 19871381
BUSINESS ADDRESS:
STREET 1: /O BICYCLE THERAPEUTICS LIMITED
STREET 2: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
BUSINESS PHONE: 011441223261503
MAIL ADDRESS:
STREET 1: /O BICYCLE THERAPEUTICS LIMITED
STREET 2: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
FORMER NAME:
FORMER CONFORMED NAME: Cambridge Innoation Capital (Jersey) Ltd
DATE OF NAME CHANGE: 20190515
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc
CENTRAL INDEX KEY: 0001761612
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
BUSINESS PHONE: 011441223261503
MAIL ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
FORMER COMPANY:
FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd
DATE OF NAME CHANGE: 20181212
4
1
a4.xml
4
X0306
4
2019-05-28
0
0001761612
BICYCLE THERAPEUTICS plc
BCYC
0001776911
Cambridge Innovation Capital (Jersey) Ltd
C/O BICYCLE THERAPEUTICS PLC
B900, BABRAHAM RESEARCH CAMPUS
CAMBRIDGE
X0
CB22 3AT
UNITED KINGDOM
0
0
1
0
Ordinary Shares
2019-05-28
4
C
0
1081823
A
1081823
D
Ordinary Shares
2019-05-28
4
X
0
125587
A
1207410
D
Ordinary Shares
2019-05-28
4
C
0
229741
A
1437151
D
Ordinary Shares
2019-05-29
4
P
0
314286
14
A
1751437
D
Series B1 Preferred Shares
2019-05-28
4
C
0
1081823
D
Ordinary Shares
1081823
0
D
Series B1 Preferred Shares Warrants
2019-05-28
4
X
0
125587
D
Ordinary Shares
125587
0
D
Series B2 Preferred Shares
2019-05-28
4
C
0
229741
D
Ordinary Shares
229741
0
D
Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date.
Upon conversion of all of the Series B1 Preferred Shares into Ordinary Shares in connection with the Issuer's initial public offering, the Warrants became exercisable for Ordinary Shares. The Warrants had an exercise price of a nominal value per share and were exercised immediately prior to completion of the Issuer's initial public offering.
/s/ Rob Sprawson By: Rob Sprawson Its: Director
2019-05-31